PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Clinical Trial ID NCT01333033

Rank	Title	Journal	Year	PubWeight™‹?›
1	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
2	Current strategies in chemoradiation for esophageal cancer.	J Gastrointest Oncol	2014	0.92
3	Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.	J Hematol Oncol	2013	0.84
4	The clinical evaluation of novel imaging methods for cancer management.	Nat Rev Clin Oncol	2012	0.80
5	Adjuvant therapy in esophagogastric adenocarcinoma: controversies and consensus.	Gastrointest Cancer Res	2012	0.80
6	Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus.	Curr Treat Options Oncol	2015	0.76
7	Phase II study of bevacizumab and preoperative chemoradiation for esophageal adenocarcinoma.	J Gastrointest Oncol	2016	0.75
8	Locally advanced gastroesophageal junction tumor: a treatment dilemma.	Oncologist	2015	0.75
9	Operable gastro-oesophageal junctional adenocarcinoma: Where to next?	World J Gastrointest Oncol	2014	0.75
10	Change in chemotherapy during concurrent radiation followed by surgery after a suboptimal positron emission tomography response to induction chemotherapy improves outcomes for locally advanced esophageal adenocarcinoma.	Cancer	2016	0.75